Interim Results

RNS Number : 8568I
Marwyn Value Investors Limited
25 November 2008
 



Marwyn Value Investors Limited 


Interim results restatement for the six months ended 30 June 2008 (unaudited)


Marwyn Value Investors Limited (formerly Marwyn Value Investors II Limited) (the 'Company'), (AIM: MVI), today announces that, in preparation for its proposed move to the Specialist Fund Market of the London Stock Exchange plc, it has undertaken a review of its financial statements for the six months ended 30 June 2008 (announced on 30 September 2008).


This review has no impact on the net asset values previously announced or future net asset values. 


In connection with the review, the Company has restated its interim results to treat the amalgamation of Marwyn Value Investors II Limited and Marwyn Value Investors Limited in April 2008 as an acquisition (rather than a merger) for accounting purposes, as consistent with International Financial Reporting Standards and on which basis the full year audited results to 31 December 2008 will be prepared. The adjustments result in a restatement of the Company's interim results, which are set out below. The restatement has no impact on the Company's net asset values as stated in its announcement of 10 November 2008 or future net asset values, no impact on the assets or liabilities of the Company (including the end of period cash position of £0.3 million) and an upwards adjustment to the income statement.


As announced on 3 November 2008 and subject to the approval by the UK Listing Authority of the prospectus to be issued in connection with the admission to the Specialist Fund Market and the approval of the London Stock Exchange plc, trading on the Specialist Fund Market is expected to commence on or around 8 December 2008. 


The restated interim results will shortly be available on the Company's website www.marwynvalue.com. 



Enquiries:




Collins Stewart Europe Limited


Nominated Adviser


Seema Paterson, Stewart Wallace

0207 523 8350


  Marwyn Value Investors Limited


INCOME STATEMENT

FOR THE SIX MONTH PERIOD ENDED 30 JUNE 2008




For the six month period


For the six month period



ended 30 June 2008


ended 30 June 2007



(unaudited)


(unaudited)














Revenue

Capital


Total


Revenue

Capital


Total



£

£


£


£

£


£

INCOME











Bank interest


6,270 


6,270 


23,197 


23,197 

Excess of net assets acquired over cost


8,418,391 


8,418,391 



 (Loss)/Gain on investments held at 











 fair value through profit or loss 


(11,554,378)


(11,554,378)


8,865,396 


8,865,396 














6,270 

(3,135,987)


(3,129,717)


23,197 

8,865,396 


8,888,593 












EXPENSES











Directors' fees


26,721 


26,721 


24,699 


24,699 

Administration fees


40,051 


40,051 


16,689 


16,689 

Legal and professional fees


8,490 


8,490 



Regulatory expenses


7,410 


7,410 


7,445 


7,445 

Audit fees


9,484 


9,484 


4,000 


Registrars fees


3,026 


3,026 


6,793 


6,793 

Exempt fee


600 


600 


1,200 


1,200 

Formation expenses




8,800 


8,800 

Other expenses


10,665 


10,665 


21,320 


21,320 














106,447 


106,447 


90,946 


90,946 



 

 


 


 

 


 












(LOSS)/PROFIT FOR THE PERIOD


(100,177)

(3,135,987)


(3,236,164)


(67,749)

8,865,396 


8,797,647 












Return per Ordinary Share -











basic (pence per share)


(0.26)

(8.26)


(8.52)


(0.21)

26.86 


26.66 












Return per Ordinary Share -











diluted (pence per share)


(0.26)

(8.26)


(8.52)


(0.08)

10.58 


10.50 












The total column of this statement represents the Income Statement of the Company, prepared in accordance with IFRS. The revenue and capital columns represent supplementary information prepared under guidance published by the Association of Investment Trust Companies. All items in the above statement derive from continuing operations.




BALANCE SHEET

30 JUNE 2008





30 June 2008


31 December 2007




(unaudited)


(audited)

NON CURRENT ASSETS



£


£

Unquoted investments held at fair value through






profit or loss



89,047,801 


41,069,330 







CURRENT ASSETS






Prepayments



20,544 


Cash and cash equivalents



317,420 


273,834 




337,964 


273,834 







TOTAL ASSETS



89,385,765 


41,343,164 







CURRENT LIABILITIES






Accruals



(96,324)


(38,463)




 


 

NET ASSETS



89,289,441 


41,304,701 







EQUITY






Called up share capital



8,215,647 


3,300,000 

Share premium



43,780,480 


Special distributable reserve



26,346,979 


26,346,979 

Warrant reserve



4,392,660 


Series One Warrant reserve




1,015,866 

Series Two Warrant reserve




852,017 

Capital reserve - Unrealised



6,773,342 


9,909,330 

Revenue reserve



(219,668)


(119,491)







TOTAL EQUITY



89,289,441 


41,304,701 


Net asset value per Ordinary share - basic and






diluted (pence per share)



108.68 


125.17 



  STATEMENT OF CHANGES IN EQUITY

FOR THE SIX MONTH PERIOD ENDED 30 JUNE 2008




Called up share capital

Share premium

Special distributable reserve

Warrant reserve

Series One Warrant Reserve

Series Two Warrant Reserve

Capital reserve

Revenue reserve


Total



£

£

£

£

£

£

£

£


£













As at 1 January 2008 

3,300,000 

26,346,979 

1,015,866 

852,017 

9,909,330 

(119,491)


41,304,701 













Issue of Ordinary Shares 











and Warrants


4,915,647 

44,486,609 

4,431,235 

(1,015,866)

(852,017)


51,965,608 













Amalgamation 

expenses (note 4)

(706,129)

(38,575)


(744,704)













(Loss)/Profit for the period

(3,135,987)

(100,177)


(3,236,164)













As at 30 June 2008

8,215,647 

43,780,480 

26,346,979 

4,392,660 

6,773,343 

(219,668)

 

89,289,441 




Called up share capital

Share premium

Special distributable reserve

Warrant reserve

Series One Warrant Reserve

Series Two Warrant Reserve

Capital reserve

Revenue reserve


Total



£

£

£

£

£

£

£

£


£













Issue of Ordinary Shares 











and Warrants


3,300,000 

27,733,798 

1,069,338 

896,864 


33,000,000 













Profit for the period

8,865,396 

(67,749)


8,797,647 













Share and warrant 

issue costs

(1,386,819)

(53,472)

(44,847)


(1,485,138)













Transfer to Special 











Distributable Reserve


(26,346,979)

26,346,979 














As at 30 June 2007

3,300,000 

26,346,979 

1,015,866 

852,017 

8,865,396 

(67,749)

 

40,312,509 



  

CASH FLOW STATEMENT

FOR THE SIX MONTH PERIOD ENDED 30 JUNE 2008




For the six month period


For the six month period



30 June 2008


30 June 2007



(unaudited)


(unaudited)



£


£

Net cash outflow from operating activities


(811,805)


(57,330)

Net cash inflow/(outflow) from investing activities


720,000 


(31,160,000)






Net cash outflow before financing


(91,805)


(31,217,330)






Net cash inflow from financing activities


135,391 


31,514,862 






Increase in cash and cash equivalents


43,586 


297,532 






Cash and cash equivalents at beginning of period


273,834 







Cash and cash equivalents at end of period


317,420 


297,532 


These interim financial statements are unaudited and are not the Company's statutory financial statements.




NOTES TO THE CONDENSED INTERIM FINANCIAL STATEMENTS

30 JUNE 2008



1. GENERAL INFORMATION

On 18th April 2008 Marwyn Value Investors Limited, company no 44223, and Marwyn Value Investors II Limited, company no 45443 were amalgamated in accordance the Amalgamation of Companies Ordinance 1997: To continue trading as Marwyn Value Investors II Limited. Following the sanction of a special resolution of the Company, and with the approval of the Royal Court of Guernsey, dated 25th April 2008, the Company changed its name and is now called Marwyn Value Investors Limited.


2. ACCOUNTING POLICIES

These unaudited interim financial statements, which have not been reviewed by an independent auditor, have been prepared in accordance with International Accounting Standard 34: Interim Financial Reporting ('IAS 34'). These interim financial statements have adopted the same accounting policies, presentation and methods of computation as the last financial statements which were prepared in accordance with International Financial Reporting Standards ('IFRS') issued by the International Accounting Standards Board ('IASB'), interpretations issued by the International Financial Reporting Interpretations Committee of the IASB ('IFRIC') and applicable legal and regulatory requirements of Guernsey Law.


3. THE AMALGAMATION

On 11 March 2008, the Directors of Marwyn Value Investors Limited ('Marwyn') and Marwyn Value Investors II Limited ('MVI2') announced that they had reached agreement on the terms of a recommended amalgamation between MVI2 and Marwyn pursuant to which Marwyn would be amalgamated with MVI2. Under the amalgamation; (i) the Marwyn Ordinary Shares and Marwyn B Shares were converted into MVI2 Shares; (ii) MVI2 Series One Warrants and MVI2 Series Two Warrants were cancelled in exchange for New Warrants; and (iii) Marwyn Series Two Warrants and Marwyn B Warrants were cancelled in exchange for New Warrants.


The amalgamation was implemented under the Guernsey Amalgamation of Companies Ordinance, 1997 such that MVI2 as the surviving or Amalgamated Company did, by operation of law, succeed to all property, rights powers and privileges, and did become liable for all debts, liabilities and obligations, of Marwyn existing on the Effective Date, 18 April 2008. On the Effective Date, all Marwyn Shares were converted into MVI2 Shares and Marwyn ceased to exist as a separate entity under Guernsey law and was deleted from the Guernsey Register of Companies. Thereafter, the Company was amalgamated for the purposes of the Ordinance.


The number of shares to which Marwyn Shareholders became entitled under the Amalgamation was determined on the calculation date, 11 April 2008, when the Fair Asset Values were calculated in accordance with the formulae set out in part XI of the AIM re-admission document.


A Marwyn Ordinary Shareholder was entitled to 1.2232408 New Shares for every Marwyn Ordinary Share held; and


A Marwyn B Shareholder was entitled to 0.7796110 New Shares for Every Marwyn B Share held.


Fractional entitlements to Shares arising after calculation of each Marwyn Shareholder's entitlement under the terms of the Amalgamation were disregarded and were not issued.


On that basis the Amalgamation resulted in the issue of 49,156,473 New Shares representing 59.83% of the enlarged share capital of MVI2. The fair value of the shares issued was £60,212,747 or 122.492 pence per share as at the Calculation Date. No warrants were exercised at the Amalgamation.


Under the Marwyn Warrant Proposals agreed at meetings of the Marwyn Warrantholders and Existing MVI2 Warrantholders all Marwyn Warrants were cancelled from the Effective Date, 18 April 2008. In consideration for agreeing to such cancellation Marwyn Warrantholders received New Warrants on the following basis:  

for every Marwyn Series Two Warrant cancelled 0.6318 New Warrants; and 

for every Marwyn B Warrant cancelled 0.3571 New Warrants.


In consideration for agreeing to the cancellation of the MVI2 Warrants, MVI2 Warrantholders received New Warrants on the following basis:

for every MVI2 Series One Warrant cancelled 0.3571 New Warrants; and

for every MVI2 Series Two Warrant cancelled 0.1648 New Warrants.


Fractional entitlements to New Warrants arising after calculation of each Warrantholders entitlement under the terms of the Warrant Proposals were disregarded and not issued.


On the basis described above, the Amalgamation resulted in the issue of 23,259,078 New Warrants. As of the Effective Date, the Marwyn Shares, the Existing MVI2 Shares, Marwyn Warrants and the Existing MVI2 Warrants were no longer admitted to trading on AIM and were cancelled.


4. AMALGAMATION EXPENSES

The expenses directly attributable to the amalgamation of Marwyn Value Investors Limited and Marwyn Value Investors II Limited consist of the costs attributable to the issue of shares and warrants associated with the amalgamation are taken to the Share premium and Warrant reserve accounts.


5. ADMISSION TO TRADING ON AIM

Application was made to the London Stock Exchange for all of the Existing MVI2 Shares to be re-admitted to trading on AIM and for the New Shares to be issued pursuant to the Amalgamation and for all of the New Warrants to be issued as outlined in the Warrant Proposals, to be admitted to trading on AIM. Admission became effective and dealings on AIM for normal settlement in the MVI2 Shares and New Warrants commenced on 18 April 2008.


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IR KELBLVFBZFBZ
UK 100

Latest directors dealings